126768-40-9 Usage
Uses
Used in Pharmaceutical Industry:
5-METHYL-2-THIOPHENECARBOXYLIC ACID HYDRAZIDE is used as a building block for the synthesis of various organic compounds, contributing to the development of new drugs. Its unique chemical structure allows for the creation of diverse pharmaceutical agents with potential therapeutic applications.
Used as a Reagent in Organic Synthesis:
In the field of organic synthesis, 5-METHYL-2-THIOPHENECARBOXYLIC ACID HYDRAZIDE serves as a valuable reagent. Its ability to participate in various chemical reactions facilitates the synthesis of a wide range of organic compounds, making it an essential component in research and development laboratories.
Safety Precautions:
It is crucial to handle 5-METHYL-2-THIOPHENECARBOXYLIC ACID HYDRAZIDE with caution due to its potential health risks if not used properly. Adequate safety measures should be taken to minimize exposure and ensure the well-being of individuals working with this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 126768-40-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,7,6 and 8 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126768-40:
(8*1)+(7*2)+(6*6)+(5*7)+(4*6)+(3*8)+(2*4)+(1*0)=149
149 % 10 = 9
So 126768-40-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2OS/c1-4-2-3-5(10-4)6(9)8-7/h2-3H,7H2,1H3,(H,8,9)
126768-40-9Relevant academic research and scientific papers
BORON CONTAINING COMPOUNDS AND THEIR USES
-
Paragraph 0219; 0221, (2021/01/23)
The present disclosure contemplates a boron-containing compound, a composition containing a pesticidal effective amount of that compound dissolved or dispersed in a carrier medium, and a method of reducing, ameliorating, or controlling an infestation by a pest, particularly a fungus, by administering a contemplated composition to a plant or animal in need.
AZOLE DERIVATIVES AS WTN PATHWAY INHIBITORS
-
Page/Page column 129-130, (2010/12/29)
The present invention relates to new compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy. Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway. For example, these may be used in preventing and/or retarding proliferation of tumor cells, for example carcinomas such as colon carcinomas.
